Related Experiment Videos
[Chlamydia pneumoniae, atherosclerosis, and coronary disease]
Rosa Monno1, Matteo Di Biase, Antonella Costi
1Sezione di Igiene Cattedra di Microbiologia Dipartimento di Medicina Interna e Medicina Pubblica Università degli Studi Policlinico Piazza Giulio Cesare, 11 70124 Bari. r.monno@igiene-seconda.uniba.it
Summary
Chlamydia pneumoniae infections are increasingly linked to atherosclerosis and cardiovascular events like heart attack and stroke. Research explores the connection between this infection and heart disease, including potential antibiotic treatments.
Area of Science:
- Infectious Diseases
- Cardiovascular Medicine
- Pathology
Context:
- Growing evidence links Chlamydia pneumoniae infection to atherosclerosis.
- Epidemiological studies show associations between Chlamydia pneumoniae antibodies and cardiovascular disease.
- Chlamydia pneumoniae, its antigens, or nucleic acid have been detected in atherosclerotic plaques.
Purpose:
- To review the multifaceted evidence connecting Chlamydia pneumoniae to atherosclerosis.
- To explore the proposed mechanisms by which Chlamydia pneumoniae contributes to atherosclerosis.
- To summarize findings on the efficacy of antibiotic treatment for cardiovascular events in humans.
Summary:
- This review consolidates evidence linking Chlamydia pneumoniae infections to atherosclerosis and its clinical outcomes, including unstable angina, myocardial infarction, and stroke.
- It examines epidemiological data, direct detection of the pathogen in plaques, and experimental findings elucidating its pathogenic role.
- The review also covers human studies investigating the impact of antibiotic therapy on cardiovascular events.
Impact:
- Highlights the role of infectious agents in cardiovascular disease pathogenesis.
- Informs potential therapeutic strategies targeting Chlamydia pneumoniae for atherosclerosis management.
- Provides a comprehensive overview for researchers and clinicians in infectious disease and cardiology.